Genetic Polymorphism PC-1 K121Q and Ethnic Susceptibility to Insulin Resistance

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 12, 2003, Pages 5927-5934

  Abate, Nicola ^a,b   Carulli, Lucia ^a   Cabo Chan Jr , Alberto ^a   Chandalia, Manisha ^a   Snell, Peter G ^a   Grundy, Scott M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN PC 1 K121Q; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASIAN; CAUCASIAN; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN EXPERIMENT; HYPERINSULINEMIA; INDIAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; GLUTAMINE; HUMANS; HYPERINSULINISM; INDIA; INSULIN RESISTANCE; LYSINE; MALE; MIDDLE AGED; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, GENETIC; PYROPHOSPHATASES;

EID: 0347993139     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030453     Document Type: Article

References (48)

1. Fontbonne A. M., Eschwege, E. M 1991 Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care 14:461-469
2. Pyorala, M., Miettinen, H., Laakso, M., Pyorala, K 1998 Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation 98:398-404
3. Pyorala K, Savolainen E, Kaukola S, Haapakoski J 1985 Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701:(Suppl)38-52
4. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ 1996 Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957
5. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R 1996 Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 93:809-817
6. Reaven GM 1988 Role of insulin resistance in human disease. Diabetes 37: 1595-1607
7. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C 1993 Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329:1988-1992
8. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK 1990 Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 39:283-288
9. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY 1990 Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104-111
10. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege E 1991 Risk factors for NIDDM in white population. Paris prospective study. Diabetes 40:796-799
11. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Reaven G 1985 Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 248:286-291
12. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM 1995 Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest 96:88-98
13. UK Prospective Diabetes Study Group 1994 UK Prospective Diabetes Study. XII. Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. Diabetic Med 11:670-677
14. McKeigue PM, Shah B, Marmot MG 1991 Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386
15. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy S. M 1999 Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84:2329-2335
16. Dowse GK, Gareeboo H, Zimmet PZ, Alberti KG, Tuomilehto J, Fareed D, Brissonnette LG, Finch CF 1990 High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes 39:390-396
17. Ramachandran A, Snehlatha C, Dharmaraj D, Viswanathan M 1992 Prevalence of glucose intolerance in Asian Indians. Urban-rural difference and significance of upper body adiposity. Diabetes Care 15:1348-1355
18. Ramachandran A, Jali MV, Mohan V, Snehalatha C, Viswanathan M 1988 High prevalence of diabetes in an urban population in south India. Br Med J 297:587-90
19. Mather HM, Keen H 1985 The Southall Diabetes Survey: prevalence of known diabetes in Asians and Europeans. Br Med J 291:1081-1084
20. McKeigue PM, Miller GJ, Marmot MG 1989 Coronary heart disease in south Asians overseas. J Clin Epidemiol 42:597-609
21. Sarvotham SG, Berry JN 1968 Prevalence of coronary heart disease in an urban population in northern India. Circulation 37:939-953
22. Dewan BD, Malhotra KC, Gupta SP 1974 Epidemiological study of coronary heart disease in rural community in Haryana. Indian Heart J 26:68-78
23. Chadha SL, Radhakrishnan S, Ramachandran K, Kaul U, Gopinath N 1990 Epidemiological study of coronary heart disease in urban population of Delhi. Indian J Med Res 92:424-430
24. Beckles GL, Miller GJ, Kirkwood BR, Alexis SD, Carson DC, Byam NT 1986 High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet 1:1298-1301
25. Groop L 2000 Genetics of the metabolic syndrome. Br J Nutr 83:39-48
26. Almind K, Inoue G, Pedersen O, Kahn CR 1996 A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. J Clin Invest 97:2569-2575
27. 972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocrinol Metab 85:2004-2013
28. Celi FS, Silver K, Waltson J, Knowler WC, Bogardus C, Shuldiner AR 1995 Lack of IRS-1 codon 513 and 972 polymorphism in Pima Indians. J Clin Endocrinol Metab 80:2827-2829
29. Hitman GA, Hawrami K, McCarthy MI, Viswanathan M, Snehalatha C, Ramachandran A, Tuomilehto J, Tuomilehto-Wolf E, Nissinen A, Pedersen O 1995 Insulin receptor substrate-1 gene mutations in MDDM; implications for the study of polygenic disease. Diabetologia 38:481-486
30. Pizzutti A, Frittitta L, Argiolas A, Baratta R, Goldfine ID, Bozzali M, Ercolino T, Scarlato G, Iacoviello L, Vigneri R, Tassi V, Trischitta V 1999 A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 48:1881-1884
31. Frittitta L, Baratta R, Spampinato D, Di Paola R, Pizzuti A, Vigneri R, Trischitta V 2001 The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance. J Clin Endocrinol Metab 86:5888-5891
32. Maddux BA, Sbraccia P, Kamakura S, Sasson S, Youngren J, Fisher A, Spencer S, Grupe A, Henzel W, Stewart TA 1995 Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus. Nature 373:443-451
33. Maddux BA, Goldfine ID 2000 Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor α-subunit. Diabetes 49:13-19
34. Kumakuia S, Maddux BA, Sung CK 1998 Overexpression of membrane glycoprotein PC-1 can influence insulin action at a post-receptor site. J Cell Biochem 3:366-377
35. Youngren J, Maddux BA, Sasson S, Sbraccia P, Tapscott EB, Swanson MS, Dohm GL, Goldfine ID 1996 Skeletal muscle content of membrane glycoprotein PC-1 in obesity. Relationship to muscle glucose transport. Diabetes 45:1324-1328
36. Frittitta L, Youngren J, Sbraccia P, D'Adamo M, Buongiorno A, Vigneri R, Goldfine ID, Trischitta V 1997 Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-α gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity. Diabetologia 40:282-289
37. Frittitta L, Spampinato D, Solini A, Nosadini R, Goldfine ID, Vigneri R, Trischitta V 1998 Elevated PC-1 content in cultured skin fibroblasts correlates with decreased in vivo and in vitro insulin action in nondiabetic subjects: evidence that PC-1 may be an intrinsic factor in impaired insulin receptor signaling. Diabetes 47:1095-1100
38. Costanzo BV, Trischitta V, Di Paola R, Spampinato D, Pizzuti A, Vigneri R, Frittitta L 2001 The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 50:831-836
39. Frittitta L, Youngren J, Vigneri R, Maddux BA, Trischitta V, Goldfine ID 1996 PC-1 content in skeletal muscle of non-obese, non-diabetic subjects: relationship to insulin receptor tyrosine kinase and whole body insulin sensitivity. Diabetologia 39:1190-1195
40. Siri WE 1961 Techniques for measuring body composition. Washington DC: National Academy of Sciences; 223-224
41. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223
42. Gu HF, Almgren P, Lindholm E, Frittitta L, Pizzuti A, Trischitta V, Groop LC 2000 Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes 49:1601-1603
43. Kubaszek A, Pihlajamaki J, Karhapaa P, Vauhkonen I, Laakso M 2003 The K121Q polymorphism of the PC-1 gene is associated with insulin resistance but not with dyslipidemia. Diabetes Care 26:464-467
44. González-Sánchez JL, Martínez-Larrad MT, Fernández-Pérez C, Kubaszek A, Laakso M, Serrano-Ríos M 2003 K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population. Obes Res 11: 603-605
45. Rasmussen SK, Urhammer SA, Pizzuti A, Echwald SM, Ekstrom CT, Hansen L, Hansen T, Borch-Johnsen K, Frittitta L, Trischitta V, Pedersen O 2000 The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians. Diabetes 49:1608-1611
46. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC 2001 Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism 10:1197-1202
47. Neel JV 1962 Diabetes mellitus: a thrifty genotype rendered detrimental by progress. Am J Hum Genet 14:353-362
48. Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, Haraldsdottir J, Borch-Johnsen K 1995 Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397-402